Clinical Trial Update: The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of venetoclax and obinutuzumab in chronic lymphocytic leukemia is ongoing, with the study currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Gazyva (Obinutuzumab)
• Venclyxto (Venetoclax)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Chronic Lymphocytic Leukemia (CLL) | Phase 2 | Status: ACTIVE_NOT_RECRUITING